{"title":"Intravenous therapy for the treatment of multiple sclerosis","authors":"Professor Michael Hutchinson, Karl Nichol, Mhairi Nellis, Jeanette Spicer, Elspeth Wolfenden","doi":"10.1002/fps.4","DOIUrl":null,"url":null,"abstract":"<p>Multiple Sclerosis (MS) is a multi-focal disease of the central nervous system (CNS) that is characterised by inflammation, demyelination and axonal degeneration. In the majority of MS patients, the disease presents with a relapsing remitting course at disease onset. Relapsing remitting MS (RRMS); affects around two thirds of the 85 000 people in the UK with MS.<sup>1</sup> The aims of treatment in RRMS are not only to prevent the rate of relapse, but also to slow down patients' disability progression. Copyright © 2007 Wiley Interface Ltd</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"8 1","pages":"15-20"},"PeriodicalIF":0.0000,"publicationDate":"2008-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.4","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Multiple Sclerosis (MS) is a multi-focal disease of the central nervous system (CNS) that is characterised by inflammation, demyelination and axonal degeneration. In the majority of MS patients, the disease presents with a relapsing remitting course at disease onset. Relapsing remitting MS (RRMS); affects around two thirds of the 85 000 people in the UK with MS.1 The aims of treatment in RRMS are not only to prevent the rate of relapse, but also to slow down patients' disability progression. Copyright © 2007 Wiley Interface Ltd
静脉注射治疗多发性硬化
多发性硬化症(MS)是一种中枢神经系统(CNS)的多灶性疾病，以炎症、脱髓鞘和轴突变性为特征。在大多数多发性硬化症患者中，疾病在发病时呈现复发缓解过程。复发缓解型MS (RRMS);在英国85000名ms患者中，约有三分之二受到影响。RRMS治疗的目的不仅是防止复发率，而且要减缓患者的残疾进展。版权所有©2007 Wiley Interface Ltd
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
